Plant ID: NPO11791
Plant Latin Name: Magnolia obovata
Taxonomy Genus: Magnolia
Taxonomy Family: Magnoliaceae
NCBI TaxonomyDB:
349509
Plant-of-the-World-Online:
554784-1
Japan; South Korea; China
CNR1; ADRA2C; ADRA2A; CNR2; | |
TSHR; NMUR2; | |
GAA; ACHE; | |
GLA; ALOX15; PTPRCAP; POLB; | |
MAPK1; | |
CA2; CA12; CA9; CA3; CA4; | |
PPARA; PPARD; | |
RXRA; | |
ALOX5; XDH; | |
CASP1; CASP7; | |
MMP2; | |
TLR2; | |
HIF1A; | |
RAB9A; LMNA; FABP3; FABP5; FABP2; FABP4; MAPT; |
Cytochrome P450 Enzymes: | CYP3A4; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cysteine protease | CASP1 | Caspase-1 | P29466 | CHEMBL4801 |
Cysteine protease | CASP7 | Caspase-7 | P55210 | CHEMBL3468 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | GLA | Alpha-galactosidase A | P06280 | CHEMBL2524 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | PTPRCAP | Protein tyrosine phosphatase receptor type C-associated protein | Q14761 | CHEMBL4806 |
Enzyme_unclassified | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Hydrolase | ACHE | Acetylcholinesterase | P22303 | CHEMBL220 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA3 | Carbonic anhydrase III | P07451 | CHEMBL2885 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Metallo protease | MMP2 | Matrix metalloproteinase-2 | P08253 | CHEMBL333 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Nuclear hormone receptor subfamily 2 group B | RXRA | Retinoid X receptor alpha | P19793 | CHEMBL2061 |
Oxidoreductase | ALOX5 | Arachidonate 5-lipoxygenase | P09917 | CHEMBL215 |
Oxidoreductase | XDH | Xanthine dehydrogenase | P47989 | CHEMBL1929 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Peptide receptor (family A GPCR) | NMUR2 | Neuromedin-U receptor 2 | Q9GZQ4 | CHEMBL1075144 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Small molecule receptor (family A GPCR) | CNR1 | Cannabinoid CB1 receptor | P21554 | CHEMBL218 |
Small molecule receptor (family A GPCR) | ADRA2C | Alpha-2c adrenergic receptor | P18825 | CHEMBL1916 |
Small molecule receptor (family A GPCR) | ADRA2A | Alpha-2a adrenergic receptor | P08913 | CHEMBL1867 |
Small molecule receptor (family A GPCR) | CNR2 | Cannabinoid CB2 receptor | P34972 | CHEMBL253 |
Toll-like and Il-1 receptors | TLR2 | Toll-like receptor 2 | O60603 | CHEMBL4163 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Unclassified | RAB9A | Ras-related protein Rab-9A | P51151 | CHEMBL1293294 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
Unclassified | FABP2 | Fatty acid binding protein intestinal | P12104 | CHEMBL4879 |
Unclassified | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 4.988E-11 | 5.430E-07 | CA12, CA2, CA3, CA4, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 6.088E-09 | 1.105E-05 | CA12, CA2, CA3, CA4, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.735E-08 | 2.699E-05 | CA12, CA2, CA3, CA4, CA9 |
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 1.250E-07 | 1.361E-04 | FABP2, FABP3, FABP4, FABP5 |
BP | GO:0008152; metabolic process | GO:0051001; negative regulation of nitric-oxide synthase activity | 2.070E-07 | 1.960E-04 | CNR1, CNR2, GLA |
BP | GO:0050896; response to stimulus | GO:0001666; response to hypoxia | 4.304E-07 | 3.347E-04 | CASP1, HIF1A, LMNA, MMP2, PPARA, PPARD, TLR2 |
BP | GO:0050896; response to stimulus | GO:0010243; response to organonitrogen compound | 8.612E-07 | 5.705E-04 | CASP1, CASP7, CNR1, CNR2, FABP3, MAPK1, MMP2, PPARA, TLR2, TSHR |
BP | GO:0050896; response to stimulus | GO:0033993; response to lipid | 5.149E-06 | 2.116E-03 | CA2, CA9, CASP1, CNR1, CNR2, FABP3, PPARD, RXRA, TLR2 |
BP | GO:0050896; response to stimulus | GO:0042493; response to drug | 6.084E-06 | 2.366E-03 | CA3, CA9, CASP1, CNR1, CNR2, FABP3, MAPK1, POLB, TLR2 |
BP | GO:0050896; response to stimulus | GO:0050727; regulation of inflammatory response | 6.313E-06 | 2.411E-03 | CASP1, CNR1, CNR2, FABP4, PPARA, PPARD, TLR2 |
BP | GO:0051179; localization | GO:0015908; fatty acid transport | 7.162E-06 | 2.643E-03 | FABP3, NMUR2, PPARA, PPARD |
MF | GO:0060089; molecular transducer activity | GO:0004949; cannabinoid receptor activity | 1.012E-05 | 3.355E-03 | CNR1, CNR2 |
MF | GO:0060089; molecular transducer activity | GO:0004938; alpha2-adrenergic receptor activity | 1.012E-05 | 3.355E-03 | ADRA2A, ADRA2C |
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 1.340E-05 | 4.229E-03 | CA12, CA2, CA3, CA4, CA9, MMP2, PPARA, PPARD, RXRA |
BP | GO:0023052; signaling | GO:0050796; regulation of insulin secretion | 1.592E-05 | 4.914E-03 | ADRA2A, ADRA2C, CNR1, HIF1A, PPARD |
BP | GO:0065007; biological regulation | GO:0006919; activation of cysteine-type endopeptidase activity involved in apoptotic process | 1.602E-05 | 4.914E-03 | CASP1, CASP7, MAPT, XDH |
BP | GO:0032501; multicellular organismal process | GO:0001816; cytokine production | 1.681E-05 | 5.015E-03 | CASP1, FABP4, HIF1A, TLR2 |
BP | GO:0065007; biological regulation | GO:0035625; epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway | 2.022E-05 | 5.655E-03 | ADRA2A, ADRA2C |
BP | GO:0009987; cellular process | GO:0032811; negative regulation of epinephrine secretion | 2.022E-05 | 5.655E-03 | ADRA2A, ADRA2C |
BP | GO:0009987; cellular process | GO:0038171; cannabinoid signaling pathway | 2.022E-05 | 5.655E-03 | CNR1, CNR2 |
CC | GO:0016020; membrane | GO:0005886; plasma membrane | 2.089E-05 | 5.697E-03 | ACHE, ADRA2A, ADRA2C, ALOX15, CA12, CA2, CA4, CA9, CNR1, CNR2, FABP5, GAA, MAPK1, MAPT, MMP2, NMUR2, PTPRCAP, RAB9A, TLR2, TSHR |
CC | GO:0016020; membrane | GO:0016323; basolateral plasma membrane | 2.321E-05 | 6.090E-03 | ADRA2A, CA2, CA4, CA9, TSHR |
BP | GO:0008152; metabolic process | GO:0006691; leukotriene metabolic process | 2.578E-05 | 6.605E-03 | ALOX15, ALOX5, TLR2 |
BP | GO:0023052; signaling | GO:0032228; regulation of synaptic transmission, GABAergic | 2.841E-05 | 7.194E-03 | CA2, CNR1, CNR2 |
MF | GO:0005488; binding | GO:0051379; epinephrine binding | 9.390E-05 | 1.733E-02 | ADRA2A, ADRA2C |
CC | GO:0044464; cell part | GO:0030424; axon | 1.079E-04 | 1.895E-02 | ADRA2C, CA2, CNR1, MAPK1, MAPT |
CC | GO:0044464; cell part | GO:0032838; plasma membrane bounded cell projection cytoplasm | 2.624E-04 | 3.421E-02 | HIF1A, MAPK1, MAPT |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 3.281E-11 | 4.626E-09 | FABP2, FABP3, RXRA, FABP4, FABP5, PPARA, PPARD |
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 8.618E-11 | 6.076E-09 | CA12, CA3, CA2, CA4, CA9 |
09130 Environmental Information Processing | 09133 Signaling molecules and interaction | hsa04080 | Neuroactive ligand-receptor interaction | 9.185E-06 | 4.317E-04 | CNR2, CNR1, NMUR2, ADRA2C, ADRA2A, TSHR |
09160 Human Diseases | 09167 Infectious diseases | hsa05134 | Legionellosis | 1.318E-04 | 4.644E-03 | CASP7, CASP1, TLR2 |
09160 Human Diseases | 09161 Cancers | hsa05205 | Proteoglycans in cancer | 4.706E-04 | 9.480E-03 | MMP2, MAPK1, HIF1A, TLR2 |
09160 Human Diseases | 09161 Cancers | hsa05200 | Pathways in cancer | 6.825E-04 | 1.203E-02 | RXRA, MMP2, MAPK1, HIF1A, PPARD |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 2.814E-04 | 7.775E-03 | RXRA, CA2, CYP3A4 |
09160 Human Diseases | 09167 Infectious diseases | hsa05133 | Pertussis | 3.308E-04 | 7.775E-03 | CASP7, CASP1, MAPK1 |
09150 Organismal Systems | 09155 Excretory system | hsa04964 | Proximal tubule bicarbonate reclamation | 7.783E-04 | 1.219E-02 | CA2, CA4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.240E-03 | 1.248E-02 | ALOX15, CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
G00-G99: Diseases of the nervous system G00-G99 | Epileptic seizures | G40, P90, R56 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Pain | G64, G90.0, R52, G89 | CNR2; ACHE; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Poisoning due to pesticides and chemicals | T36-T50 | ACHE; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MMP2; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | CNR2; |
C00-D49: Neoplasms | Non-small-cell lung cancer | NA | MMP2; |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Neurodegenerative disease | G30-G32 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Neuropathic pain | G64, G90.0 | CNR2; |
L00-L99: Diseases of the skin and subcutaneous tissue | Atopic dermatitis | L00-L99 | CNR2; |
C00-D49: Neoplasms | Cutaneous T-cell lymphoma | C84.0, C84.1 | RXRA; |
A00-B99: Certain infectious and parasitic diseases | Pediculus humanus capitis | B85.0 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Myasthenia gravis diagnosis | G70.0 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Myasthenia gravis | G70.0 | ACHE; |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | CNR2; |
K00-K95: Diseases of the digestive system | Inflammatory bowel disease | K50, K51 | CNR2; |
G00-G99: Diseases of the nervous system G00-G99 | Parkinson's disease | G20 | ACHE; |
C00-D49: Neoplasms | Pancreatic cancer | C25 | MMP2; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | ACHE; |
C00-D49: Neoplasms | Cancer | C00-C96 | ACHE; MMP2; |
H00-H59: Diseases of the eye and adnexa | Chronic glaucoma | H40-H42 | ACHE; |
C00-D49: Neoplasms | Ovarian cancer | C56 | MMP2; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | ACHE; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Osteoporosis | M80-M81, Z79.890 | CNR2; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Osteoarthritis | M15-M19, M47 | MMP2; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | ACHE; |
C00-D49: Neoplasms | Lung cancer | C33-C34 | MMP2; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | ACHE; |
A00-B99: Certain infectious and parasitic diseases | Helminth infection | A00-B99 | ACHE; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Mild cognitive impairment | F06.7 | ACHE; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Poison intoxication | T36-T50 | ACHE; |
NA: NA | Early satiation associated with functional dyspepsia | NA | ACHE; |
K00-K95: Diseases of the digestive system | Xerostomia | K11.7, R68.2 | ACHE; |
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | Immune disorder | D80-D89 | CNR2; |
L00-L99: Diseases of the skin and subcutaneous tissue | Acne vulgaris | L70.0 | MMP2; |
NA: NA | Upper abdominal bloating | NA | ACHE; |
N00-N99: Diseases of the genitourinary system | Urinary dysfunction | N39.3-N39.4 | ACHE; |
C00-D49: Neoplasms | Renal cell carcinoma | NA | MMP2; |